Quick Answer
Processa Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 2.57 million shares for the year ending 2025.
- Processa Pharmaceuticals, Inc. showed an increase of +1,636.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2013 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2013 to 2025), Processa Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has declined by 68.2%.
- Historical annual values: Fiscal year 2025: 2.57 million shares | Fiscal year 2024: 148,108 shares | Fiscal year 2024: 1.29 million shares | Fiscal year 2023: 1.29 million shares | Fiscal year 2022: 801,774 shares | Fiscal year 2021: 15.71 million shares | Fiscal year 2020: 14.18 million shares | Fiscal year 2019: 5.49 million shares | Fiscal year 2018: 5.53 million shares | Fiscal year 2017: 35.27 million shares | Fiscal year 2016: 31.75 million shares | Fiscal year 2015: 11.02 million shares | Fiscal year 2014: 10.95 million shares | Fiscal year 2013: 8.08 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: